Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

2.
4.
6.

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.

Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA.

BMJ. 2005 Dec 17;331(7530):1431-7. Epub 2005 Nov 10.

7.
8.

Cost-effectiveness of selected interventions for hearing impairment in Africa and Asia: a mathematical modelling approach.

Baltussen R, Smith A.

Int J Audiol. 2009 Mar;48(3):144-58. doi: 10.1080/14992020802538081.

PMID:
19283586
9.

Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.

Adam T, Lim SS, Mehta S, Bhutta ZA, Fogstad H, Mathai M, Zupan J, Darmstadt GL.

BMJ. 2005 Nov 12;331(7525):1107.

10.

Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.

Baltussen R, Naus J, Limburg H.

Health Policy. 2009 Feb;89(2):201-15. doi: 10.1016/j.healthpol.2008.06.003. Epub 2008 Jul 14.

PMID:
18621429
11.

Cost effectiveness analysis of strategies for tuberculosis control in developing countries.

Baltussen R, Floyd K, Dye C.

BMJ. 2005 Dec 10;331(7529):1364. Epub 2005 Nov 10.

12.

Cost-effectiveness of malaria control in sub-Saharan Africa.

Goodman CA, Coleman PG, Mills AJ.

Lancet. 1999 Jul 31;354(9176):378-85.

PMID:
10437867
13.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.

PMID:
10485721
14.

Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.

Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I.

Vaccine. 2013 Dec 29;31 Suppl 5:F60-72. doi: 10.1016/j.vaccine.2012.07.093.

PMID:
24331749
15.

GDP Matters: Cost Effectiveness of Cochlear Implantation and Deaf Education in Sub-Saharan Africa.

Emmett SD, Tucci DL, Smith M, Macharia IM, Ndegwa SN, Nakku D, Mukara KB, Ibekwe TS, Mulwafu W, Gong W, Francis HW, Saunders JE.

Otol Neurotol. 2015 Sep;36(8):1357-65. doi: 10.1097/MAO.0000000000000823. Erratum in: Otol Neurotol. 2015 Dec;36(10):1765. Kaitesi, Mukara B [Corrected to Mukara, Kaitesi B].

PMID:
26244622
16.

Costs, Effectiveness, and Cost-Effectiveness of Selected Surgical Procedures and Platforms.

Prinja S, Nandi A, Horton S, Levin C, Laxminarayan R.

In: Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN, editors. Essential Surgery: Disease Control Priorities, Third Edition (Volume 1). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Apr 2. Chapter 18.

17.

Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.

Kuznik A, Habib AG, Munube D, Lamorde M.

BMC Health Serv Res. 2016 Jul 26;16:304. doi: 10.1186/s12913-016-1572-6.

18.

Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.

Fernandes S, Sicuri E, Kayentao K, van Eijk AM, Hill J, Webster J, Were V, Akazili J, Madanitsa M, ter Kuile FO, Hanson K.

Lancet Glob Health. 2015 Mar;3(3):e143-53. doi: 10.1016/S2214-109X(14)70385-7.

19.

Cost Effectiveness of Childhood Cochlear Implantation and Deaf Education in Nicaragua: A Disability Adjusted Life Year Model.

Saunders JE, Barrs DM, Gong W, Wilson BS, Mojica K, Tucci DL.

Otol Neurotol. 2015 Sep;36(8):1349-56. doi: 10.1097/MAO.0000000000000809.

PMID:
26171672
20.

Cost effectiveness analysis of strategies to combat malaria in developing countries.

Morel CM, Lauer JA, Evans DB.

BMJ. 2005 Dec 3;331(7528):1299. Epub 2005 Nov 10. Erratum in: BMJ. 2006 Jul 8;333(7558):86. BMJ. 2006 Jan 21;332(7534):151.

Supplemental Content

Support Center